Skip to main content
Log in

Postprandial anti-hyperglycemic effect of vitamin B6 (pyridoxine) administration in healthy individuals

  • Published:
Food Science and Biotechnology Aims and scope Submit manuscript

Abstract

Postprandial blood glucose lowering effect of vitamin B6 (pyridoxine) was evaluated in healthy individuals with normal blood glucose levels. Blood glucose levels were measured every 30 min for 2 h after oral sugar administration with or without 50 mg of pyridoxine. Pyridoxine significantly lowered the postprandial blood glucose levels at 30 min (from 165.95 ± 17.19 to 138.36 ± 20.43, p < 0.01) and 60 min (from 131.40 ± 17.20 to 118.50 ± 15.95) after administration. In addition, the area under the concentration–time curve (AUCt) was reduced by about 8.3% (from 257.08 ± 22.38 to 235.71 ± 12.33, p < 0.05) and the maximum concentration of blood glucose (Cmax) was reduced by about 13.8% (from 165.95 ± 17.19 to 143.07 ± 11.34, p < 0.01) when compared with those of the control group. Our findings suggest that pyridoxine supplementation may be beneficial for controlling postprandial hyperglycemia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 35: S64–S71 (2012)

    Google Scholar 

  • Bender DA. The Vitamins. pp. 132–187. In: Introduction to human nutrition. Gibney MJ, Lanham-New SA, Cassidy A, Vorster HH. (ed). John Wiley & Sons, Inc., Hoboken, NJ, USA (2009)

  • Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul. Health Metr. 8: 29 (2010)

    Article  PubMed  PubMed Central  Google Scholar 

  • Centers for Disease Control and Prevention. Diabetes Report Card 2014. Centers for Disease Control and Prevention, US Department of Health and Human Services, Atlanta, GA, USA (2015)

  • Hou CT, Wu YH, Huang PN, Cheng CH, Huang YC. Higher plasma pyridoxal 5′-phosphate is associated with better blood glucose responses in critically ill surgical patients with inadequate vitamin B-6 status. Clin. Nutr. 30: 478–483 (2011)

    Article  CAS  PubMed  Google Scholar 

  • Hsu CC, Cheng CH, Hsu CL, Lee WJ, Huang SC, Huang YC. Role of vitamin B6 status on antioxidant defenses, glutathione, and related enzyme activities in mice with homocysteine-induced oxidative stress. Food Nutr. Res. 59: 25702 (2015)

    Article  CAS  PubMed  Google Scholar 

  • Kannan K, Jain SK. Effect of vitamin B6 on oxygen radicals, mitochondrial membrane potential, and lipid peroxidation in H2O2-treated U937 monocytes. Free Radic. Biol. Med. 36: 423–428 (2004)

    Article  CAS  PubMed  Google Scholar 

  • Kim HW, Kang YR, Lee JY, Chang HB, Lee KW, Apostolidis E, Kwon YI. The postprandial anti-hyperglycemic effect of pyridoxine and its derivatives using in vitro and in vivo animal models. Nutrients. 10: 285–296 (2018)

    Article  CAS  PubMed Central  Google Scholar 

  • Morris MS, Picciano MF, Jacques PF, Selhub J. Plasma pyridoxal 5-phosphate in the US population: the National Health and Nutrition Examination Survey, 2003–20041–4. Am. J. Clin. Nutr. 87: 1446–1454 (2008)

    Article  CAS  PubMed  Google Scholar 

  • Odum EP, Wakwe VC. Plasma concentrations of water soluble vitamins in metabolic syndrome subjects. Niger. J. Clin. Pract. 15: 442–447 (2012)

    Article  CAS  PubMed  Google Scholar 

  • Roth-Maier DA, Kettler SI, Kirchgessner M. Availability of vitamin B6 from different food sources. Int. J. Food Sci. Nutr. 53: 171–179 (2002)

    Article  CAS  PubMed  Google Scholar 

  • Van de Laar FA. Alpha-glucosidase inhibitors in the early treatment of type 2 diabetes. Vasc. Health Risk Manag. 4: 1189–1195 (2008)

    Article  PubMed  PubMed Central  Google Scholar 

  • Van de Laar FA, Lucassen PL, Akkermans RP, Van de Lisdonk EH, Rutten GE, Van Weel C. Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis. Diabetes Care. 28: 154–163 (2005)

    Article  PubMed  Google Scholar 

  • Wei EK, Giovannucci E, Selhub J, Fuchs CS, Hankinson SE, Ma J. Plasma vitamin B6 and the risk of colorectal cancer and adenoma in women. J. Natl. Cancer Inst. 97: 684–692 (2005)

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This research was financially supported by the Ministry of Trade, Industry, and Energy (MOTIE), Korea, under the “Regional Specialized Industry Development Program” supervised by the Korea Institute for Advancement of Technology (KIAT).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Young-In Kwon.

Ethics declarations

Conflicts of interest

The authors declare no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, H.H., Kang, YR., Choi, HY. et al. Postprandial anti-hyperglycemic effect of vitamin B6 (pyridoxine) administration in healthy individuals. Food Sci Biotechnol 28, 907–911 (2019). https://doi.org/10.1007/s10068-018-0534-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10068-018-0534-7

Keywords

Navigation